Galen Growth’s 2023 Europe Digital Health Innovation Year End Report is a fundamental resource, providing in-depth analysis for industry leaders, investors, and innovators. We focus our analysis on ecosystem key trends, through the lens of ecosystem growth, most active partners, regulatory approvals, key categories, therapeutic areas, venture funding, and more.
Europe’s digital health ecosystem continues to evolve. While funding levels have declined, Europe remains a dynamic hub for Digital Health innovation. Ventures are focusing on evidence-based approaches, with a growing number leveraging AI and GenAI technologies to address healthcare challenges. In 2023, the Wellness cluster gained momentum, driven by high-profile deals and innovative solutions.
Galen Growth is pleased to share with you our 2023 Year-End Report on Digital Health Key Trends in Europe. This report looks across the Digital Health startup ecosystem to reflect on the 2023 trends and move the industry forward into 2024. Our analysis focuses on private ventures and includes most active partners, regulatory approvals and venture funding strength, among others.
HealthTech Alpha, a Galen Growth proprietary solution, and the world’s leading Digital Health private market data, intel and insights platform powers this report!
The “2023 Europe Digital Health Innovation Year End Report” includes data on the following companies:
Charac, Dawn Health, Exscientia, Huma, Owkin, eGym, CMR Surgical, Volta Medical, Distalmotion, Alentis Therapeutics, Peppy, Urban Sports Club, Quell, Clinomic, Cyted, Causaly, Crescendo Biologics, BioSerenity, LUMA Vision, Patient21, Diamond Whites, Babylon Health, aidhere, Medexprim, 7Mind, PrecisionLife, Deepc, CliniNote, Quibim, Impress, eMed, Gymondo, Oura, NHS, Novartis, Merck, Merck KGaA, Servier, BC Platforms, Absci, BT Health, Philips, Affinity Partners, Softbank, Ally Bridge Group, Escala Capital, Revival Healthcare Capital, Pitango Venture Capital, Verdane Capital
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com
| TL;DR | ||
| HEADLINES: 9 pages, 14 charts, 4 tables | ||
| ECOSYSTEM INSIGHTS: 4 pages, 7 charts, 2 tables | ||
| INVESTMENT INSIGHTS: 4 pages, 6 charts | ||
| CLUSTER FOCUS: 4 pages, 3 charts, 1 table | ||
| THERAPEUTIC FOCUS: 3 pages, 3 charts, 1 table | ||
| DEEP DIVES: 17 pages, 25 charts, 4 tables | ||
| NOTEWORTHY: 3 pages, 3 tables | ||
| KEY INFORMATION |
